[Form 4] Robinhood Markets, Inc. Insider Trading Activity
Form 4 insider activity 鈥� ClearPoint Neuro, Inc. (CLPT)
Chief Business Officer Jeremy L. Stigall purchased 1,608 shares of ClearPoint Neuro common stock on 06/30/2025 through the company鈥檚 Employee Stock Purchase Plan (ESPP). The acquisition price was $10.15, reflecting the ESPP鈥檚 15 % discount to the lower of the market prices on the first or last day of the six-month purchase period (01/01/2025-06/30/2025). After the transaction, Stigall directly owns 72,355 CLPT shares.
No shares were sold and no derivative securities were involved. While the purchase is modest in size, insider buying鈥攅specially by a senior officer鈥攖ends to be interpreted as a sign of management鈥檚 confidence in the company鈥檚 prospects, albeit with limited immediate financial impact.
Attivit脿 insider modulo 4 鈥� ClearPoint Neuro, Inc. (CLPT)
Il Chief Business Officer Jeremy L. Stigall ha acquistato 1.608 azioni di ClearPoint Neuro tramite il Piano di Acquisto Azionario per Dipendenti (ESPP) il 30/06/2025. Il prezzo di acquisto 猫 stato di 10,15 $, corrispondente allo sconto del 15% previsto dall鈥橢SPP sul prezzo di mercato pi霉 basso tra il primo e l鈥檜ltimo giorno del periodo di acquisto di sei mesi (01/01/2025-30/06/2025). Dopo questa operazione, Stigall detiene direttamente 72.355 azioni CLPT.
Non sono state vendute azioni n茅 coinvolti strumenti derivati. Sebbene l鈥檃cquisto sia di entit脿 contenuta, l鈥檃cquisto da parte di un dirigente 猫 generalmente interpretato come un segnale di fiducia della direzione nelle prospettive dell鈥檃zienda, anche se con un impatto finanziario immediato limitato.
Actividad interna formulario 4 鈥� ClearPoint Neuro, Inc. (CLPT)
El Director de Negocios, Jeremy L. Stigall, compr贸 1,608 acciones ordinarias de ClearPoint Neuro el 30/06/2025 a trav茅s del Plan de Compra de Acciones para Empleados (ESPP) de la empresa. El precio de adquisici贸n fue de $10.15, reflejando el descuento del 15% del ESPP sobre el precio de mercado m谩s bajo entre el primer y 煤ltimo d铆a del per铆odo de compra de seis meses (01/01/2025-30/06/2025). Tras esta operaci贸n, Stigall posee directamente 72,355 acciones CLPT.
No se vendieron acciones ni se utilizaron valores derivados. Aunque la compra es modesta, la adquisici贸n por parte de un alto ejecutivo suele interpretarse como una se帽al de confianza de la direcci贸n en las perspectivas de la empresa, aunque con un impacto financiero inmediato limitado.
Form 4 雮措秬鞛� 瓯半灅 鈥� ClearPoint Neuro, Inc. (CLPT)
斓滉碃靷梾毂呾瀯鞛� Jeremy L. Stigall鞚� 2025雲� 6鞗� 30鞚� 須岇偓鞚� 歆侅洂 欤检嫕 甑Г 瓿勴殟(ESPP)鞚� 韱淀暣 1,608欤�鞚� ClearPoint Neuro 氤错喌欤茧ゼ 毵れ瀰頄堨姷雼堧嫟. 毵れ瀰 臧�瓴╈潃 $10.15搿�, 6臧滌洈 甑Г 旮瓣皠(2025雲� 1鞗� 1鞚紐6鞗� 30鞚�) 觳偁瓿� 毵堨毵� 雮� 欷� 雿� 雮潃 鞁滌灔 臧�瓴╈棎 15% 頃犾澑鞚� 鞝侅毄霅� ESPP 臧�瓴╈瀰雼堧嫟. 瓯半灅 頉� Stigall鞚� 歆侅爲 72,355欤�鞚� CLPT 欤检嫕鞚� 氤挫湢頃橁碃 鞛堨姷雼堧嫟.
欤检嫕 毵る弰雮� 韺岇儩靸來拡 瓯半灅電� 鞐嗢棃鞀惦媹雼�. 攴滊電� 韥 鞎婌毵�, 瓿犾渼 鞛勳洂鞚� 雮措秬鞛� 毵れ垬電� 瓴届榿歆勳澊 須岇偓 鞝勲鞐� 鞛愳嫚臧愳潉 臧�歆�瓿� 鞛堨潓鞚� 雮橅儉雮措姅 鞁犿樃搿� 頃挫劃霅橂姅 瓴届毎臧� 毵庫溂氅�, 歃夑皝鞝侅澑 鞛 鞓來枼鞚� 鞝滍暅鞝侅瀰雼堧嫟.
Activit茅 d鈥檌niti茅 formulaire 4 鈥� ClearPoint Neuro, Inc. (CLPT)
Le Chief Business Officer Jeremy L. Stigall a achet茅 1 608 actions ordinaires de ClearPoint Neuro le 30/06/2025 via le Plan d鈥橝chat d鈥橝ctions des Employ茅s (ESPP) de la soci茅t茅. Le prix d鈥檃cquisition 茅tait de 10,15 $, refl茅tant la remise de 15 % de l鈥橢SPP sur le cours le plus bas du march茅 entre le premier et le dernier jour de la p茅riode d鈥檃chat de six mois (01/01/2025-30/06/2025). Apr猫s cette transaction, Stigall d茅tient directement 72 355 actions CLPT.
Aucune action n鈥檃 茅t茅 vendue et aucun instrument d茅riv茅 n鈥檃 茅t茅 utilis茅. Bien que l鈥檃chat soit modeste, l鈥檃cquisition par un cadre sup茅rieur est g茅n茅ralement per莽ue comme un signe de confiance de la direction dans les perspectives de l鈥檈ntreprise, bien que l鈥檌mpact financier imm茅diat soit limit茅.
Formular 4 Insider-Aktivit盲t 鈥� ClearPoint Neuro, Inc. (CLPT)
Chief Business Officer Jeremy L. Stigall erwarb am 30.06.2025 1.608 Aktien von ClearPoint Neuro 眉ber den Employee Stock Purchase Plan (ESPP) des Unternehmens. Der Kaufpreis betrug 10,15 $ und entspricht dem 15%-Rabatt des ESPP auf den niedrigeren der Marktpreise am ersten oder letzten Tag des sechsmonatigen Kaufzeitraums (01.01.2025鈥�30.06.2025). Nach der Transaktion besitzt Stigall direkt 72.355 CLPT-Aktien.
Es wurden keine Aktien verkauft und keine Derivate verwendet. Obwohl der Kaufvolumen gering ist, wird der Kauf durch einen leitenden Angestellten oft als Zeichen f眉r das Vertrauen des Managements in die Zukunftsaussichten des Unternehmens gewertet, wenn auch mit begrenzter unmittelbarer finanzieller Auswirkung.
- Insider purchase: Chief Business Officer acquired 1,608 shares, boosting direct ownership to 72,355 and signaling incremental management confidence.
- None.
Insights
TL;DR: Small ESPP buy; positive signal but immaterial to fundamentals.
Stigall鈥檚 1,608-share purchase marginally increases his stake, taking advantage of the standard 15 % ESPP discount. The filing shows no sales or option exercises, implying a net commitment of capital. Although insider buying is directionally constructive鈥攅specially from a C-suite executive鈥攖he dollar value and share count are too small to alter valuation models or liquidity. The event is best viewed as a mild vote of confidence rather than a catalyst.
Attivit脿 insider modulo 4 鈥� ClearPoint Neuro, Inc. (CLPT)
Il Chief Business Officer Jeremy L. Stigall ha acquistato 1.608 azioni di ClearPoint Neuro tramite il Piano di Acquisto Azionario per Dipendenti (ESPP) il 30/06/2025. Il prezzo di acquisto 猫 stato di 10,15 $, corrispondente allo sconto del 15% previsto dall鈥橢SPP sul prezzo di mercato pi霉 basso tra il primo e l鈥檜ltimo giorno del periodo di acquisto di sei mesi (01/01/2025-30/06/2025). Dopo questa operazione, Stigall detiene direttamente 72.355 azioni CLPT.
Non sono state vendute azioni n茅 coinvolti strumenti derivati. Sebbene l鈥檃cquisto sia di entit脿 contenuta, l鈥檃cquisto da parte di un dirigente 猫 generalmente interpretato come un segnale di fiducia della direzione nelle prospettive dell鈥檃zienda, anche se con un impatto finanziario immediato limitato.
Actividad interna formulario 4 鈥� ClearPoint Neuro, Inc. (CLPT)
El Director de Negocios, Jeremy L. Stigall, compr贸 1,608 acciones ordinarias de ClearPoint Neuro el 30/06/2025 a trav茅s del Plan de Compra de Acciones para Empleados (ESPP) de la empresa. El precio de adquisici贸n fue de $10.15, reflejando el descuento del 15% del ESPP sobre el precio de mercado m谩s bajo entre el primer y 煤ltimo d铆a del per铆odo de compra de seis meses (01/01/2025-30/06/2025). Tras esta operaci贸n, Stigall posee directamente 72,355 acciones CLPT.
No se vendieron acciones ni se utilizaron valores derivados. Aunque la compra es modesta, la adquisici贸n por parte de un alto ejecutivo suele interpretarse como una se帽al de confianza de la direcci贸n en las perspectivas de la empresa, aunque con un impacto financiero inmediato limitado.
Form 4 雮措秬鞛� 瓯半灅 鈥� ClearPoint Neuro, Inc. (CLPT)
斓滉碃靷梾毂呾瀯鞛� Jeremy L. Stigall鞚� 2025雲� 6鞗� 30鞚� 須岇偓鞚� 歆侅洂 欤检嫕 甑Г 瓿勴殟(ESPP)鞚� 韱淀暣 1,608欤�鞚� ClearPoint Neuro 氤错喌欤茧ゼ 毵れ瀰頄堨姷雼堧嫟. 毵れ瀰 臧�瓴╈潃 $10.15搿�, 6臧滌洈 甑Г 旮瓣皠(2025雲� 1鞗� 1鞚紐6鞗� 30鞚�) 觳偁瓿� 毵堨毵� 雮� 欷� 雿� 雮潃 鞁滌灔 臧�瓴╈棎 15% 頃犾澑鞚� 鞝侅毄霅� ESPP 臧�瓴╈瀰雼堧嫟. 瓯半灅 頉� Stigall鞚� 歆侅爲 72,355欤�鞚� CLPT 欤检嫕鞚� 氤挫湢頃橁碃 鞛堨姷雼堧嫟.
欤检嫕 毵る弰雮� 韺岇儩靸來拡 瓯半灅電� 鞐嗢棃鞀惦媹雼�. 攴滊電� 韥 鞎婌毵�, 瓿犾渼 鞛勳洂鞚� 雮措秬鞛� 毵れ垬電� 瓴届榿歆勳澊 須岇偓 鞝勲鞐� 鞛愳嫚臧愳潉 臧�歆�瓿� 鞛堨潓鞚� 雮橅儉雮措姅 鞁犿樃搿� 頃挫劃霅橂姅 瓴届毎臧� 毵庫溂氅�, 歃夑皝鞝侅澑 鞛 鞓來枼鞚� 鞝滍暅鞝侅瀰雼堧嫟.
Activit茅 d鈥檌niti茅 formulaire 4 鈥� ClearPoint Neuro, Inc. (CLPT)
Le Chief Business Officer Jeremy L. Stigall a achet茅 1 608 actions ordinaires de ClearPoint Neuro le 30/06/2025 via le Plan d鈥橝chat d鈥橝ctions des Employ茅s (ESPP) de la soci茅t茅. Le prix d鈥檃cquisition 茅tait de 10,15 $, refl茅tant la remise de 15 % de l鈥橢SPP sur le cours le plus bas du march茅 entre le premier et le dernier jour de la p茅riode d鈥檃chat de six mois (01/01/2025-30/06/2025). Apr猫s cette transaction, Stigall d茅tient directement 72 355 actions CLPT.
Aucune action n鈥檃 茅t茅 vendue et aucun instrument d茅riv茅 n鈥檃 茅t茅 utilis茅. Bien que l鈥檃chat soit modeste, l鈥檃cquisition par un cadre sup茅rieur est g茅n茅ralement per莽ue comme un signe de confiance de la direction dans les perspectives de l鈥檈ntreprise, bien que l鈥檌mpact financier imm茅diat soit limit茅.
Formular 4 Insider-Aktivit盲t 鈥� ClearPoint Neuro, Inc. (CLPT)
Chief Business Officer Jeremy L. Stigall erwarb am 30.06.2025 1.608 Aktien von ClearPoint Neuro 眉ber den Employee Stock Purchase Plan (ESPP) des Unternehmens. Der Kaufpreis betrug 10,15 $ und entspricht dem 15%-Rabatt des ESPP auf den niedrigeren der Marktpreise am ersten oder letzten Tag des sechsmonatigen Kaufzeitraums (01.01.2025鈥�30.06.2025). Nach der Transaktion besitzt Stigall direkt 72.355 CLPT-Aktien.
Es wurden keine Aktien verkauft und keine Derivate verwendet. Obwohl der Kaufvolumen gering ist, wird der Kauf durch einen leitenden Angestellten oft als Zeichen f眉r das Vertrauen des Managements in die Zukunftsaussichten des Unternehmens gewertet, wenn auch mit begrenzter unmittelbarer finanzieller Auswirkung.
FAQ
What did ClearPoint Neuro's Form 4 filed on 07/02/2025 report?
How many CLPT shares did Jeremy L. Stigall purchase?
At what price were the ESPP shares acquired?
What is Stigall's total share ownership after the transaction?
Did the filing report any sale of ClearPoint Neuro shares?
Why is the purchase price discounted under the ESPP?
